Bank of New York Mellon Corp
BankPosition in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1390777
NEW YORK, NY
Position in TEVA
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$54,048,287
-$3,120,375 QoQ
Shares Held
1,794,432
-2.0% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $1,372,047,844 across 46 Drug Manufacturers - Specialty & Generic names. TEVA ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,899,720 | $460,985,889 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
329,148 | $195,178,172 | |
| 3 | VTRS |
Viatris Inc
|
14,128,917 | $190,881,662 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
702,492 | $92,546,288 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,809,888 | $91,170,611 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
1,794,432 | $54,048,287 | |
| 7 | ALKS |
Alkermes plc.
|
1,036,460 | $36,649,221 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
463,751 | $35,175,507 |
All Filings in TEVA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $54,048,287 | 1,794,432 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $57,168,662 | 1,831,742 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $33,618,090 | 1,664,262 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $28,204,342 | 1,682,837 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $24,741,022 | 1,609,696 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $35,734,420 | 1,621,344 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $27,998,986 | 1,553,773 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $26,035,960 | 1,602,213 | Shares | Other | 2024-07-25 | |
| 2024-03-31 | $23,073,628 | 1,635,268 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $19,469,291 | 1,864,875 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $19,402,795 | 1,902,235 | Shares | Other | 2023-10-24 | |
| 2023-06-30 | $14,173,934 | 1,882,329 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $15,977,504 | 1,805,368 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $17,015,794 | 1,865,767 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $14,977,377 | 1,855,933 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,844,745 | 1,841,057 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $17,609,946 | 1,875,394 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $14,790,253 | 1,846,474 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $17,465,764 | 1,793,200 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $17,429,767 | 1,760,583 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $22,418,408 | 1,942,670 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $18,151,785 | 2,014,627 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $24,871,985 | 2,017,193 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $16,987,231 | 1,891,674 | Shares | Other | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||